Effectiveness and Tolerability of Olanzapine in the Treatment of Adolescents with Schizophrenia and Related Psychotic Disorders: Results from a Large, Prospective, Open-Label Study-Reference-Cited by-同舟云学术

Effectiveness and Tolerability of Olanzapine in the Treatment of Adolescents with Schizophrenia and Related Psychotic Disorders: Results from a Large, Prospective, Open-Label Study

Published:2008-02 Issue:1 Volume:18 Page:54-69
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

Dittmann Ralf W.¹²,Meyer Eberhard³,Freisleder Franz Joseph⁴,Remschmidt Helmut⁵,Mehler-Wex Claudia⁶,Junghanss Jenny⁷,Hagenah Ulrich⁸,Schulte-Markwort Michael²,Poustka Fritz⁹,Schmidt Martin H.¹⁰,Schulz Eberhard¹¹,Mästele Anneliese¹,Wehmeier Peter M.¹

Affiliation:

1. Medical Department, Child and Adolescent Psychiatry, Lilly Deutschland GmbH, Bad Homburg, Germany.

2. Department of Child and Adolescent Psychosomatic Medicine, University of Hamburg, Germany.

3. Hospital for Child and Adolescent Psychiatry and Psychotherapy, Riedstadt, Germany.

4. Heckscher-Hospital for Child and Adolescent Psychiatry and Psychotherapy, Munich, Germany.

5. Department of Child and Adolescent Psychiatry and Psychotherapy, University of Marburg.

6. Department of Child and Adolescent Psychiatry and Psychotherapy, University of Würzburg, Germany.

7. Department of Child and Adolescent Psychiatry, Children Hospital Josefinum, Augsburg, Germany.

8. Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital Aachen, Germany.

9. Department of Psychiatry and Psychotherapy in Children and Adolescents, J.W. Goethe University Frankfurt, Germany.

10. Department of Psychiatry and Psychotherapy in Children and Adolescents, Central Institute of Mental Health, Mannheim, Germany.

11. Department of Psychiatry and Psychotherapy in Children and Adolescents, University of Freiburg, Germany.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology and Child Health

Link

http://www.liebertpub.com/doi/pdf/10.1089/cap.2006.0137

Reference33 articles.

1. Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus

2. Do we need placebos to evaluate new drugs in children with schizophrenia?

3. Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial

4. Olanzapine versus Placebo and Haloperidol

5. Age at Onset in Subtypes of Schizophrenic Disorders

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recognizing, Managing and Treating Acute Agitation in Youths;Current Pharmaceutical Design;2022-09

2. Influencia del sexo en el tratamiento con olanzapina: una revisión sistemática;Psiquiatría Biológica;2019-05

3. Inpatient psychiatric treatment is not always effective in adolescent sample;International Journal of Psychiatry in Clinical Practice;2017-08-21

4. Therapeutic Drug Monitoring in Children and Adolescents Under Pharmacotherapy With Olanzapine in Daily Clinical Practice;Therapeutic Drug Monitoring;2017-06

5. Spontaneous Ejaculations in an Adolescent With Olanzapine Use;Clinical Neuropharmacology;2016-05